Chronic inflammation and the metabolic syndrome

Česká verzia

Authors: Š. Svačina
Authors place of work: III. interní klinika 1. lékařské fakulty UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA
Published in the journal: Vnitř Lék 2012; 58(7 a 8): 205-207
Category: 60th Birthday prof. MUDr. Miroslav Souček, CSc.

Summary

Metabolic syndrome is a disease associated with systemic inflammation. At present, metabolic syndrome is understood chiefly as an abdominal obesity with complications. Inflammatory signs then have the strongest association with the wasteline. Nevertheless, metabolic syndrome is most certainly also induced by an inflammation of a different origin. Metabolic syndrome is linked to typically inflammatory diseases such as paradontosis, rheumatoid diseases, chronic obstructive pulmonary disease and, to a large extent, psoriasis. The association is thus certainly reciprocal; metabolic syndrome causes inflammation and inflammatory diseases cause metabolic syndrome. Pathogenic relationships are unclear while it cannot be excluded that it is primarily an inflammation that causes metabolic syndrome and, in case of abdominal obesity without another inflammatory disease, this may be an inflammation in the abdominal fat.

Key words:
metabolic syndrome – type 2 diabetes mellitus – hypertension – paradontosis – C-reactive protein – chronic obstructive pulmonary disease – rheumatoid arthritis – psoriasis

Zdroje

1. Wang M (ed.). Metabolic syndrome: Underlying Mechanisms and Drug Therapies. Hoboken, NJ, USA: John Wiley & Sons 2011.

2. Svačina Š et al. Poruchy metabolismu a výživy. Praha: Galén 2010.

3. Svačina Š et al. Metabolický syndrom. 3. rozř. a přeprac. vyd. Praha: Triton 2006.

4. Svačina Š, Souček M, Šmahelová A et al. Metabolický syndrom. 1. vyd. Praha: Grada 2011.

5. Strunecká A, Patočka J. Doba jedová 1. Praha: Triton 2011.

6. Strunecká A, Patočka J. Doba jedová 2. Praha: Triton 2012.

7. Oliveira AC, Oliveira AM, Adan LF et al. C-reactive protein and metabolic syndrome in youth: a strong relationship? Obesity (Silver Spring) 2008; 16: 1094–1098.

8. Alonso-Rodríguez C, Medina-Font J. High sensitivity C-reactive protein in airline pilots with metabolic syndrome. Aviat Space Environ Med 2012; 83: 504–508.

9. Zuliani G, Volpato S, Galvani M et al. Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study. Atherosclerosis 2009; 203: 626–632.

10. Watz H, Waschki B, Kirsten A et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest 2009; 136: 1039–1046.

11. Gisondi P, Tessari G, Conti A et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007; 157: 68–73.

12. Cohen AD, Sherf M, Vidavsky L et al. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology 2008; 216: 152–155.

13. Gelfand J, Azfar RS, Mehta NN. Psoriasis and Cardiovascular Risk: Strength in Numbers. J Invest Dermatol 2010; 130: 919–922.

14. Brauchli YB, Jick SS, Curtin F et al. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study. J Am Acad Dermatol 2008; 58: 421–429.

15. Mittal R, Malhotra S, Pandhi P et al. Efficacy and Safety of Combination Acitretin and Pioglitazone Therapy in Patients With Moderate to Severe Chronic Plaque-Type Psoriasis: a randomized, double-blind, placebo-controlled clinical trial. Arch Dermatol 2009; 145: 387–393.

16. Buysschaert M, Tennstedt D, Preumont V. Improvement of psoriasis during exenatide treatment in a patient with diabetes. Diabetes Metab 2012; 38: 86–88.

17. Farrokhi F, Taylor HC, McBride NM. Etanercept-induced hypoglycemia and improved glycemic control in a patient with type 2 diabetes. Endocr Pract 2011; 17: 306–307.

18. Wambier CG, Foss-Freitas MC, Paschoal RS et al. Severe hypoglycemia after initiation of anti-tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus. J Am Acad Dermatol 2009; 60: 883–885.

19. Preshaw PM, Alba AL, Herrera D et al. Periodontitis and diabetes: a two-way relationship. Diabetologia 2012; 55: 21–31.

20. Han DH, Lim S, Paek D et al. Periodontitis could be related factors on metabolic syndrome among Koreans: a case-control study. J Clin Periodontol 2012; 39: 30–37.

21. Vidal F, Figueredo CM, Cordovil I et al. Higher prevalence of periodontitis in patients with refractory arterial hypertension: a case-control study. Oral Dis 2011; 17: 560–563.

22. Maňka V et al. Metabolický syndrom při zápalových onemocněních spojiva. Diabetes obezita 2003; 12: 85–92.